title: Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells.
abstract: cAMP regulates integrin-dependent adhesions of vascular endothelial cells (VECs) to extracellular matrix proteins, their vascular endothelial cadherin-dependent intercellular adhesions, and their proliferation and migration in response to growth and chemotactic factors. Previously, we reported that cAMP-elevating agents differentially inhibited migration of human VECs isolated from large vascular structures (macro-VECs, human aortic endothelial cells [HAECs]) or small vascular structures (micro-VECs, human microvascular endothelial cells [HMVECs]) and that cAMP hydrolysis by phosphodiesterase (PDE)3 and PDE4 enzymes was important in coordinating this difference. Here we report that 2 cAMP-effector enzymes, namely protein kinase (PK)A and exchange protein activated by cAMP (EPAC), each regulate extracellular matrix protein-based adhesions of both macro- and micro-VECs. Of interest and potential therapeutic importance, we report that although specific pharmacological activation of EPAC markedly stimulated adhesion of micro-VECs to extracellular matrix proteins when PKA was inhibited, this treatment only modestly promoted adhesion of macro-VECs. Consistent with an important role for cAMP PDEs in this difference, PDE3 or PDE4 inhibitors promoted EPAC-dependent adhesions in micro-VECs when PKA was inhibited but not in macro-VECs. At a molecular level, we identify multiple, nonoverlapping, PKA- or EPAC-based signaling protein complexes in both macro- and micro-VECs and demonstrate that each of these complexes contains either PDE3B or PDE4D but not both of these PDEs. Taken together, our data support the concept that adhesion of macro- and micro-VECs is differentially regulated by cAMP and that these differences are coordinated through selective actions of cAMP at multiple nonoverlapping signaling complexes that contain PKA or EPAC and distinct PDE variants.
authors: Department of Pharmacology & Toxicology, Queen's University, Kingston, ON, Canada, K7L 3N6.
authors: Stuart J
authors: SJ
authors: Netherton
authors: Jayda A
authors: JA
authors: Sutton
authors: Lindsay S
authors: LS
authors: Wilson
authors: Rhonda L
authors: RL
authors: Carter
authors: Donald H
authors: DH
authors: Maurice
mesh_terms: D017920:Antiporters / Q000378:metabolism* / Q000502:physiology; D002448:Cell Adhesion / Q000502:physiology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000502:physiology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism* / Q000502:physiology; D042783:Endothelial Cells / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000201:enzymology / Q000473:pathology; D006801:Humans
chemical_list: D017920:Antiporters; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases